Sven Arke Lang
Has participated in:
-
Outcomes of elective liver surgery worldwide: a global, prospective, multicenter, cross-sectional study
-
Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy
-
Bedeutung von mTOR, HIF-1α und CREB für die Prognose von Magenkarzinompatienten
-
Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model